References
- Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39–51.
- Hussain YS, Hookham JC, Allahabadia A, et al. Epidemiology, management and outcomes of Graves’ disease - real life data. Endocrine. 2017;56(3):568–578.
- Borowiec A, Labochka D, Milczarek M, et al. Graves’ disease in children in the two decades following implementation of an iodine prophylaxis programme. Cent Eur J Immunol. 2018;43(4):399–404.
- Brent GA. Environmental exposures and autoimmune thyroid disease. Thyroid. 2010;20:755–761.
- Kaguelidou F, Carel JC, Léger J. Graves’ disease in childhood: advances in management with antithyroid drug therapy. Horm Res. 2009;71(6):310–317.
- Krassas GE, Segni M, Wiersinga WM. Childhood Graves’ ophthalmopathy: results of a European questionnaire study. Eur J Endocrinol. 2005;153:515–521.
- Szczapa-Jagustyn J, Gotz-Więckowska A, Kocięcki J. An update on thyroid-associated ophthalmopathy in children and adolescents. J Pediatr Endocrinol Metab. 2016;29(10):1115–1122.
- Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American Association of Clinical Endocrinologists. Thyroid. 2011;21:593–646..
- Ross DS, Burch HB, Cooper DS, et al. American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343–1421.
- De Luca F, Valenzise M. Controversies in the pharmacological treatment of Graves’ disease in children. Expert Rev Clin Pharmacol. 2018;11(11):1113–1121.
- Léger J, Carel JC. Arguments for the prolonged use of antithyroid drugs in children with Graves’ disease. Eur J Endocrinol. 2017;177(2):R59–R67.
- Kahaly GJ, Bartalena L, Hegedüs L, et al. European Thyroid Association Guideline for the management of Graves’ Hyperthyroidism. Eur Thyroid J. 2018 Aug;7(4):167–186.
- Minamitani K, Sato H, Ohye H, et al. Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016. Clin Pediatr Endocrinol. 2017;26(2):29–62.
- Wu VT, Lorenzen AW, Beck AC, et al. Comparative analysis of radioactive iodine versus thyroidectomy for definitive treatment of Graves disease. Surgery. 2017 Jan;161(1):147–155..
- Drews JD, Cooper JN, Onwuka EA, et al. The relationships of surgeon volume and specialty with outcomes following pediatric thyroidectomy. J Pediatr Surg. 2019. ii:S0022-3468(19)30174-5. DOI:10.1016/j.jpedsurg.2019.02.033.
- Kourime M, McGowan S, Al Towati M, et al. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling. Arch Dis Child. 2018;103(7):637–642
- Azizi F, Takyar M, Madreseh E, et al. Long-term methimazole therapy in juvenile Graves’ Disease: A Randomized Trial. Pediatrics. 2019;143(5):ii: e20183034.